Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025
Get in-depth analysis of the COVID-19 impact on the Protein Expression Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Protein Expression Market
Request For Special Pricing[173 Pages Report] The global protein expression market size is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2% between 2020 and 2025. The growth of this market is driven majorly by the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market. However, the high cost of protein expression reagents and instruments, along with increasing consolidation and high barriers for new entrants, will challenge market growth.
In 2019, therapeutic applications held the largest share of the protein expression market
Based on the applications, the protein expression industry is segmented into therapeutic, industrial, and research. Therapeutic applications accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidences of the disease and growing R&D activity. The large share of this segment can be attributed to an increase in proteomics-based research and the rising prevalence of chronic diseases across the globe.
The Asia Pacific protein expression market is expected to grow at the highest CAGR during the forecast period
Asia Pacific is expected to grow at the highest rate in the market. The major factors driving the growth of this market include high incidence of chronic diseases, increasing public and private investments, and increase in life sciences research.
Key Market Players
The prominent players in the global protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).
Thermo Fisher Scientific Inc. is the largest player in the protein expression market. The large share of this company can be attributed to its strong suite of expression vectors, reagents, competent cells, and instruments. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites give it a competitive advantage over other players in the protein expression market. The company focuses on product launches to create a strong foothold in the market. In 2018, Thermo Fisher Scientific Inc. launched the Gibco ExpiSf System, the first-ever chemically defined protein expression system. The company further intends to strengthen its presence in this market by investing in R&D. Its extensive R&D activities enable it to increase its depth of capabilities in protein expression solutions and services and to provide innovative products and services in the market space.
Scope of the Report:
|
Report Metric |
Details |
|
Market size available for years |
20182025 |
|
Base year considered |
2019 |
|
Forecast period |
20202025 |
|
Forecast units |
Value (USD) |
|
Segments covered |
System Type, Product and Service, Application, End User and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, and Rest of the World |
|
Companies covered |
Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript Biotech Corporation (US), Agilent Technologies Inc. (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories Inc. |
The research report categorizes the protein expression market into the following segments and subsegments:
By System Type
- Prokaryotic Expression Systems
- Vagus Nerve Stimulation
- Escherichia coli Systems
- Other Systems
- Insect Cell Expression Systems
- CHO Systems
- Other Systems
- Yeast Cell Expression Systems
- Kluyveromyces Lactis Systems
- Saccharomyces Systems
- Pichia Systems
- Other Systems
- Insect Cell Expression Systems
- Baculovirus Expression Systems
- Other Systems
- Cell-free Expression Systems
- Algal-based Expression Systems
By Product and Service
- Reagents
- Expression Vectors
- Competent Cells
- Instruments
- Services
By Application
- Therapeutic Applications
- Industrial Applications
- Research Applications
By End User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations (CROs)
- Other End Users
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia - Pacific
- China
- Japan
- India
- Australia
- RoAPAC
- Rest of World
- Latin America
- Middle East & Africa
Recent Developments
- In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company, Qiagen (Germany). This acquisition will help Thermo Fisher Scientific to enhance its precision medicine portfolio through molecular diagnostics and improved life sciences solutions.
- In 2020, Merck announced plans for the construction of a new biotech development facility in Switzerland. The company will be investing USD 282.5 million for this purpose. This facility is going to strengthen the companys presence in the protein expression market.
- In 2019, Agilent Technologies acquired BioTek Instruments (US). This acquisition expanded Agilents presence and expertise in cell analysis and strengthened its position in the growing immune-oncology and immunotherapy areas.
Critical questions answered in the report:
- Which regions are likely to grow at the highest CAGR?
- What are the recent trends affecting the protein expression market?
- Who are the key players in the market, and how intense is the competition?
- What are the application areas of protein expression devices?
- What are the challenges hindering the adoption of protein expression devices?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 24)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 33)
4 PREMIUM INSIGHTS (Page No. - 37)
4.1 PROTEIN EXPRESSION MARKET OVERVIEW
4.2 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION & COUNTRY (2019)
4.3 PROTEIN EXPRESSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW (Page No. - 39)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of chronic diseases
5.2.1.2 Growth in the geriatric population
5.2.1.3 Increasing demand for protein biologics
5.2.1.4 Growth in the life science and biopharmaceutical industries
5.2.1.5 Increasing research activities on recombinant-based protein expression
5.2.1.6 Availability of funding for protein-based research
5.2.2 RESTRAINTS
5.2.2.1 High cost of protein expression reagents and instruments
5.2.2.2 Increasing consolidation and high barriers for new entrants
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of microfluidics
5.2.3.2 Emerging economies offer significant growth potential
5.2.4 CHALLENGES
5.2.4.1 ContaminationA major challenge in protein purification
5.2.4.2 Complexities associated with membrane protein expression and purification
5.3 THE IMPACT OF COVID-19 OUTBREAK ON THE GROWTH OF THE PROTEIN EXPRESSION MARKET
5.3.1 VACCINE AND THERAPY DEVELOPMENT FOR COVID-19 TO BOOST THE MARKET FOR PROTEIN EXPRESSION SYSTEMS
5.3.2 INCREASING RESEARCH TO IDENTIFY IDEAL TARGET PROTEINS ON SARS-COV-2 FOR DEVELOPING THERAPIES AS WELL AS DIAGNOSTIC TESTS
5.3.3 LOGISTIC CHALLENGES DUE TO SARS-COV-2 MAY RESULT IN DELAY IN PROTEIN EXPRESSION RESEARCH
5.3.4 EFFECT OF COVID-19 ON THE PHARMACEUTICAL INDUSTRY
5.3.5 PHARMA & BIOTECH COMPANIES ARE DECREASING THEIR DEPENDENCY ON CHINA BY MOVING THEIR MANUFACTURING FACILITIES FROM CHINA TO OTHER PARTS OF THE WORLD
5.3.6 INCREASE IN GOVERNMENT FUNDING
6 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE (Page No. - 50)
6.1 INTRODUCTION
6.2 PROKARYOTIC EXPRESSION SYSTEMS
6.2.1 ESCHERICHIA COLI SYSTEMS
6.2.1.1 Increasing use of E. coli systems for the production of commercial proteins to support market growth
6.2.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS
6.3 MAMMALIAN CELL EXPRESSION SYSTEMS
6.3.1 CHINESE HAMSTER OVARY SYSTEMS
6.3.1.1 Chinese hamster ovary systems account for the largest share of the mammalian expression systems market
6.3.2 OTHER MAMMALIAN CELL SYSTEMS
6.4 INSECT CELL EXPRESSION SYSTEMS
6.4.1 BACULOVIRUS SYSTEMS
6.4.1.1 Baculovirus systems show high yield and expression level, especially for intracellular proteins
6.4.2 OTHER INSECT CELL SYSTEMS
6.5 YEAST EXPRESSION SYSTEMS
6.5.1 K. LACTIS SYSTEMS
6.5.1.1 K. lactis systems held the largest share of the yeast expression systems market in 2019
6.5.2 SACCHAROMYCES SYSTEMS
6.5.2.1 Saccharomyces systems channelize the direction of foreign proteins into secretory pathways using various signals
6.5.3 PICHIA SYSTEMS
6.5.3.1 Pichia systems are used for the production of antifreeze proteins and lytic enzymes
6.5.4 OTHER YEAST EXPRESSION SYSTEMS
6.6 CELL-FREE EXPRESSION SYSTEMS
6.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS WILL DRIVE THE GROWTH OF THIS SEGMENT
6.7 ALGAL-BASED EXPRESSION SYSTEMS
6.7.1 GROWTH IN THE VACCINES MARKET IS SUPPORTING THE GROWTH OF THIS SEGMENT
7 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE (Page No. - 63)
7.1 INTRODUCTION
7.2 REAGENTS
7.2.1 REAGENTS ARE THE LARGEST AND FASTEST-GROWING PRODUCTS IN THE PROTEIN EXPRESSION MARKET
7.3 EXPRESSION VECTORS
7.3.1 EXPRESSION VECTORS ARE FREQUENTLY USED DURING TRANSFECTION
7.4 COMPETENT CELLS
7.4.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET GROWTH
7.5 INSTRUMENTS
7.5.1 INSTRUMENTS HELP IN THE EFFICIENT TRANSFER OF GENETIC MATERIALS INTO HOST CELLS
7.6 SERVICES
7.6.1 RISING DEMAND FOR CUSTOMIZED PROTEINS TO DRIVE THE MARKET FOR SERVICES
8 PROTEIN EXPRESSION MARKET, BY APPLICATION (Page No. - 69)
8.1 INTRODUCTION
8.2 THERAPEUTIC APPLICATIONS
8.2.1 THERAPEUTIC PROTEINS ARE USED TO TREAT PATHOLOGICAL CONDITIONS
8.3 INDUSTRIAL APPLICATIONS
8.3.1 RAPID GROWTH IN THE INDUSTRIAL ENZYMES MARKET IS AN IMPORTANT DRIVER FOR THE GROWTH OF THIS SEGMENT
8.4 RESEARCH APPLICATIONS
8.4.1 INCREASING INVESTMENTS IN RESEARCH ACTIVITIES WILL DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
9 PROTEIN EXPRESSION MARKET, BY END USER (Page No. - 74)
9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PROTEIN EXPRESSION SYSTEMS
9.3 ACADEMIC RESEARCH INSTITUTES
9.3.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET GROWTH
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 INCREASING CLINICAL TRIALS AND OUTSOURCING OF PHARMACEUTICAL MANUFACTURING WILL DRIVE MARKET GROWTH
9.5 OTHER END USERS
10 PROTEIN EXPRESSION MARKET, BY REGION (Page No. - 79)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US dominates the global protein expression market
10.2.2 CANADA
10.2.2.1 Government funding for research and innovation to support market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Germany is the largest market for protein expression in Europe
10.3.2 FRANCE
10.3.2.1 Proteomics research in France is strongly supported by the government
10.3.3 UK
10.3.3.1 Surge in the prevalence of chronic diseases will drive market growth
10.3.4 ITALY
10.3.4.1 Growth in this market is driven by the increase in life sciences research projects
10.3.5 SPAIN
10.3.5.1 Spain has an established network of research centers, universities, and hospitals
10.3.6 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Growth in R&D to enhance technological capabilities in the country
10.4.2 JAPAN
10.4.2.1 Rising geriatric population to support market growth
10.4.3 INDIA
10.4.3.1 Increasing investments in proteomics research to support market growth
10.4.4 AUSTRALIA
10.4.4.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities in Australia
10.4.5 REST OF ASIA PACIFIC (ROAPAC)
10.5 REST OF THE WORLD (ROW)
10.5.1 LATIN AMERICA
10.5.1.1 Increasing research in the field of stem cells to support market growth in Latin America
10.5.2 MIDDLE EAST & AFRICA
10.5.2.1 Government investments in the healthcare sector and growing pharmaceuticals industry to drive market growth in the region
11 COMPETITIVE LANDSCAPE (Page No. - 127)
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
11.4 COMPETITIVE SCENARIO
11.4.1 KEY DEVELOPMENTS IN THE PROTEIN EXPRESSION MARKET
12 COMPANY PROFILES (Page No. - 133)
(Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view)*
12.1 THERMO FISHER SCIENTIFIC, INC.
12.2 MERCK KGAA
12.3 GENSCRIPT BIOTECH CORPORATION
12.4 AGILENT TECHNOLOGIES, INC.
12.5 TAKARA BIO, INC.
12.6 BIO-RAD LABORATORIES, INC.
12.7 LONZA
12.8 PROMEGA CORPORATION
12.9 NEW ENGLAND BIOLABS
12.11 OXFORD EXPRESSION TECHNOLOGIES LTD.
12.11 LIFESENSORS
12.12 PROTEOGENIX
12.13 SYNTHETIC GENOMICS, INC. (SGI)
12.14 PEAK PROTEINS LTD.
12.15 PROMAB BIOTECHNOLOGIES, INC.
12.16 SINO BIOLOGICAL, INC.
12.17 LUCIGEN CORPORATION.
12.18 ARTES BIOTECHNOLOGY GMBH
12.19 JENA BIOSCIENCE GMBH
12.20 BIONEER CORPORATION
12.21 LENIOBIO GMBH
*Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 165)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
LIST OF TABLES (142 TABLES)
TABLE 1 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING
TABLE 2 GLOBAL INCIDENCE OF CANCER, BY TYPE (2018)
TABLE 3 BIOLOGICS AND CELL LINES USED TO PRODUCE THEM
TABLE 4 GOVERNMENT FUNDING FOR PROTEIN-BASED RESEARCH (20172020)
TABLE 5 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 6 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 7 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 8 E. COLI SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 9 OTHER PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 10 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 11 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 12 CHO SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 13 OTHER MAMMALIAN CELL SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 14 INSECT CELL EXPRESSION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 15 INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 16 BACULOVIRUS SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 17 OTHER INSECT CELL SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 18 YEAST EXPRESSION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 19 YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 20 K. LACTIS SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 21 SACCHAROMYCES SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 22 PICHIA SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 23 OTHER YEAST SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 24 CELL-FREE EXPRESSION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 25 ALGAL-BASED EXPRESSION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 26 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 27 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 28 PROTEIN EXPRESSION VECTORS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 29 PROTEIN EXPRESSION COMPETENT CELLS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 30 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 31 PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 32 PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 33 THERAPEUTIC PROTEINS & THEIR APPLICATIONS
TABLE 34 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 20182025 (USD MILLION)
TABLE 35 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 20182025 (USD MILLION)
TABLE 36 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 20182025 (USD MILLION)
TABLE 37 PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 38 PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 20182025 (USD MILLION)
TABLE 39 PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 20182025 (USD MILLION)
TABLE 40 PROTEIN EXPRESSION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 20182025 (USD MILLION)
TABLE 41 PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 20182025 (USD MILLION)
TABLE 42 PROTEIN EXPRESSION MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 43 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 44 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 45 NORTH AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 46 NORTH AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 47 NORTH AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 48 NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 49 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 50 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 51 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 52 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 53 US: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 54 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 55 US: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 56 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 57 CANADA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 58 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 59 CANADA: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 60 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 61 EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 62 EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 63 EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 64 EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 65 EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 66 EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 67 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 68 EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 69 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 70 GERMANY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 71 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 72 GERMANY: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 73 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 74 FRANCE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 75 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 76 FRANCE: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 77 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 78 UK: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 79 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 80 UK: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 81 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 82 ITALY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 83 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 84 ITALY: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 85 SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 86 SPAIN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 87 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 88 SPAIN: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 89 ROE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 90 ROE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 91 ROE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 92 ROE: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 93 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 94 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 95 ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 96 ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 97 ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 98 ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 99 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 100 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 101 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 102 CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 103 CHINA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 104 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 105 CHINA: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 106 JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 107 JAPAN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 108 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 109 JAPAN: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 110 INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 111 INDIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 112 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 113 INDIA: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 114 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 115 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 116 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 117 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 118 ROAPAC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 119 ROAPAC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 120 ROAPAC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 121 ROAPAC: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 122 ROW: PROTEIN EXPRESSION MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 123 ROW: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 124 ROW: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 125 ROW: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 126 ROW: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 127 ROW: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 128 ROW: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 129 ROW: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 130 ROW: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 131 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 132 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 133 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 134 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 135 MEA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 20182025 (USD MILLION)
TABLE 136 MEA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 20182025 (USD MILLION)
TABLE 137 MEA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 138 MEA: PROTEIN EXPRESSION MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 139 AGREEMENTS (20172020)
TABLE 140 PRODUCT LAUNCHES (20172020)
TABLE 141 ACQUISITIONS (20172020)
TABLE 142 EXPANSIONS (20172020)
LIST OF FIGURES (29 FIGURES)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 PROTEIN EXPRESSION MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE PROTEIN EXPRESSION MARKET
FIGURE 12 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
FIGURE 13 THERAPEUTIC APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2019
FIGURE 14 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE PROTEIN EXPRESSION MARKET FROM 2020 TO 2025
FIGURE 15 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 DIABETES CASES, BY REGION, 2019 VS. 2045 (MILLION)
FIGURE 17 GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE), BY REGION, 2019 VS. 2050
FIGURE 18 NORTH AMERICA DOMINATES THE PROTEIN EXPRESSION MARKET DURING THE FORECAST PERIOD
FIGURE 19 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
FIGURE 20 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT
FIGURE 21 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
FIGURE 22 COMPETITIVE LEADERSHIP MAPPING: PROTEIN EXPRESSION MARKET
FIGURE 23 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
FIGURE 24 MERCK KGAA: COMPANY SNAPSHOT (2019)
FIGURE 25 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 26 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
FIGURE 27 TAKARA BIO, INC.: COMPANY SNAPSHOT (2019)
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
FIGURE 29 LONZA: COMPANY SNAPSHOT (2019)
The protein expression market study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for this extensive, technical, market-oriented, and commercial study of the protein expression market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the protein expression market. Primary sources from the demand side included industry experts, such as researchers & scientists. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The protein expression market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by technology, application, and region).
Data Triangulation
After arriving at the market size, the protein expression market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.
Objectives of the Study
- To define, describe, and forecast the protein expression market based on system type, product, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall protein expression market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To profile the key players and comprehensively analyze their market shares and core competencies3 in terms of market developments and growth strategies
- To track and analyze competitive developments such as agreements, partnerships, expansions, acquisitions, and product launches in the protein expression market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the protein expression market report:
Company Information
- Detailed analysis and profiling of additional market players (Up to 3)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Protein Expression Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Protein Expression Market